E-LIB Suche - Ergebnisse für: Okamoto, I.

1

4O First-line (1L) osimertinib (osi) ± platinum-pemetrexed ..:

Valdiviezo, N. ; Okamoto, I. ; Hughes, B.G.M....
ESMO Open. 9 (2024) - p. 102583 , 2024

Link: https://doi.org/10.1016/..

2

161P Intensity-modulated radiotherapy (IMRT)-adapted chemor..:

Hata, A. ; Harada, H. ; Konno, M....
ESMO Open. 9 (2024) - p. 102916 , 2024

Link: https://doi.org/10.1016/..

3

59P Datopotamab deruxtecan (Dato-DXd) in patients with prev..:

Girard, N. ; Okamoto, I. ; Lisberg, A.E....
ESMO Open. 9 (2024) - p. 102638 , 2024

Link: https://doi.org/10.1016/..

4

40 Patient-reported outcomes from the CodeBreaK 200 phase I..:

Waterhouse, D.M. ; Rothschild, S. ; Dooms, C....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S37-S38 , 2023

Link: https://doi.org/10.1016/..

5

P2.08-01 TROPION-Lung08: Datopotamab Deruxtecan Plus Pembro..:

Zhou, C. ; Levy, B.P. ; Sands, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S327-S328 , 2023

Link: https://doi.org/10.1016/..

6

MA15.10 Phase II Study of Nivolumab Plus Ipilimumab with Ch..:

Tsuchiya-Kawano, Y. ; Shiraishi, Y. ; Tachihara, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S156 , 2023

Link: https://doi.org/10.1016/..

7

Physica status solidi

Volume 99, Number 1: January 16 Physica status solidi ; Volume 99, Number 1, A

Agrawal, R. C ; Ahmed, S ; Attia, V. A... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

8

Assessment of the albumin-bilirubin grade as a prognostic f..:

Takada, K. ; Takamori, S. ; Shimokawa, M....
ESMO Open. 7 (2022) 1 - p. 100348 , 2022

Link: https://doi.org/10.1016/..

9

EP08.01-036 Low-dose EGFR-TKIs Directly Induce Maturation a..:

Inoue, H. ; Tsutsumi, H. ; Okamura, K....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S354 , 2022

Link: https://doi.org/10.1016/..

10

Erlotinib plus bevacizumab vs erlotinib monotherapy as firs..:

Yamamoto, N. ; Seto, T. ; Nishio, M....
Lung Cancer. 151 (2021) - p. 20-24 , 2021

Link: https://doi.org/10.1016/..

11

Final overall survival results of WJTOG3405, a randomized p..:

Yoshioka, H. ; Shimokawa, M. ; Seto, T....
Annals of Oncology. 30 (2019) 12 - p. 1978-1984 , 2019

Link: https://doi.org/10.1093/..

12

Effect of dose adjustment on the safety and efficacy of afa..:

Yang, J.C.-H. ; Sequist, L.V. ; Zhou, C....
Annals of Oncology. 27 (2016) 11 - p. 2103-2110 , 2016

Link: https://doi.org/10.1093/..

13

Characterization of patients at high risk of melanoma in Au..:

Müller, C. ; Wendt, J. ; Rauscher, S....
British Journal of Dermatology. 174 (2016) 6 - p. 1308-1317 , 2016

Link: https://doi.org/10.1111/..

14

Survival, quality-adjusted survival, and other clinical end..:

Langer, C J ; Hirsh, V ; Okamoto, I...
British Journal of Cancer. 113 (2015) 1 - p. 20-29 , 2015

Link: https://doi.org/10.1038/..

15

Actinic damage on the back is significantly determined byMC..:

Wendt, J. ; Rauscher, S. ; Burgstaller‐Mühlbacher, S....
British Journal of Dermatology. 171 (2014) 3 - p. 622-630 , 2014

Link: https://doi.org/10.1111/..